Literature DB >> 25462546

Therapeutic outcomes and thromboembolic events after treatment of acute arterial thromboembolism of the upper extremity.

Hyung-Kee Kim1, Heekyung Jung1, Jayun Cho1, Seung Huh2, Jong-Min Lee3, Young-Wook Kim4.   

Abstract

BACKGROUND: To investigate short- and long-term outcomes of patients with acute arterial thromboembolism of upper extremity, focusing on postoperative thromboembolic events by etiology.
METHODS: Hospital records of 53 patients (average age 70 years; males 49%) with acute arterial thromboembolism of upper extremity treated between June 1993 and December 2013 were retrospectively reviewed, evaluating patient characteristics and clinical outcomes, both short and long term. Subjects were stratified as those with (group I, 34) and without (group II, 19) atrial fibrillation as underlying cause.
RESULTS: Two patients received anticoagulation alone as conservative treatment. The remainder (n = 51) underwent surgical revascularization. Symptoms resolved in 51 patients (96%) except 2 patients with postoperative reocclusion, and there was no need of amputation in all patients. Overall inpatient mortality was 5.6% (3/53). Patients of group I suffered most of the recurrent thromboembolic events (group I: 17 events, 14 patients; group II: 2 events, 2 patients) recorded during follow-up (mean duration 56.8 ± 62.2 months). Respective event-free survival rates at 1, 3, and 5 years differed significantly by group: 77%, 44%, and 44% for group I; 100%, 100%, and 83% for group II (P = 0.004). Among 14 patients with recurrent embolic events in group I, half of the patients were not receiving anticoagulants; however, anticoagulant cessation was generally arbitrary. Overall survival rates at 1, 3, and 5 years were 82%, 69%, and 52% for group I and 84%, 78%, and 70% for group II (P = 0.21).
CONCLUSIONS: In this study, surgical treatment of acute arterial thromboembolism of upper extremity was largely successful. Especially in patients with atrial fibrillation, adequate long-term anticoagulation is indicated as prophylaxis, given the high rates of recurrent thromboembolic events.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25462546     DOI: 10.1016/j.avsg.2014.08.022

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  A Population-Based Study of Incidence, Presentation, Management and Outcome of Primary Thromboembolic Ischemia in the Upper Extremity.

Authors:  Jørgen B Vennesland; Kjetil Søreide; Jan Terje Kvaløy; Andreas Reite; Morten Vetrhus
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

2.  Effects of Five Bangladeshi Plant Extracts on In vitro Thrombolysis and Cytotoxicity.

Authors:  Raju Dash; Talha Bin Emran; Arkajyoti Paul; Mohammad Kutub Uddin Siddique; Mohammad Arfad Khan; Md Golamur Rahman; Md Shahid Sarwar; Mir Muhammad Nasir Uddin
Journal:  Pharmacognosy Res       Date:  2016 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.